Ocular Surface Disease
Laboratorios Thea S.A. focuses on dry eye disease and meibomian gland dysfunction, with interest in the relief of symptoms linked to tear film instability and eyelid margin dysfunction.
- Dry Eye Disease
- Meibomian Gland Dysfunction
- Ocular Surface Symptoms
The clinical research activity centers on treatments used in lid hygiene, artificial tears, and device-based care for patients with chronic discomfort and surface irritation.
Inflammation and Tear Biomarkers
Research interest extends to tear inflammatory cytokines, reflecting attention to the inflammatory component of ocular surface inflammation in patients with symptomatic disease.
- Tear Cytokines
- Inflammatory Markers
- Tear Film Biology
This area links symptom management with biological changes in tears associated with meibomian gland-related dry eye.
Topical Ophthalmic Care
The sponsor is involved in topical ophthalmic treatment for patients with moderate meibomian gland dysfunction, including approaches designed to support daily eye comfort and surface lubrication.
- Topical Eye Treatment
- Ophthalmic Supportive Care
- Symptom Relief
Its medical affairs activity is aligned with clinical evaluation of therapies used in routine management of dry eye symptoms.
Ocular Safety Monitoring
Safety assessment includes monitoring of intraocular pressure, indicating attention to tolerability in ophthalmic care settings where corticosteroid exposure may be relevant.
- Intraocular Pressure
- Ophthalmic Safety
- Tolerability Assessment
This safety focus supports evaluation of treatment options for patients with ocular surface disease requiring ongoing management.
